利培酮在精神分裂症患者中的应用效果

Abstract
Figure/Table
References (18)
Related Citation (15)

Download: PDF (484 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the application effect of Risperidone in patients with schizophrenia.Methods From January 2020 to December 2020,78 patients with schizophrenia admitted to Ruijin Ankang Hospital were selected.According to the random number table method,they were divided into the observation group (39 cases) and the control group (39 cases).The observation group was given Risperidone treatment,and the control group was given Olanzapine treatment.The course of treatment were twevel weeks.The levels of serum brain-derived neurotrophic factor (BDNF),insulin-like growth factor-2 (IGF-2),interleukin-13 (IL-13) and the scores of social function assessment scale (SSFPI),intelligent mental state examination scale (MMSE),positive and negative symptom scale (PANSS) were compared between the two groups before and after treatment.The efficacy and adverse drug reactions of the two groups were observed.Results The levels of serum BDNF,IGF-2 and IL-13 in the two groups after treatment were significantly higher than those in the same group before treatment,the differences were statistically significant (P＜0.05).The levels of serum BDNF and IGF-2 in the observation group were higher than those in the control group,the differences were statistically significant (P＜0.05).There was no significant difference in the level of serum IL-13 between the two groups after treatment (P＞0.05).The SSFPI and MMSE scores of the two groups after treatment were higher than those of the same group before treatment,while the PANSS score of the two groups after treatment were lower than those of the same group before treatment,the differences were statistically significant (P＜0.001).After treatment,the SSFPI and MMSE scores of the observation group were higher than those of the control group,while the PANSS scores of the observation group was lower than that of the control group,the differences were statistically significant (P＜0.05).There was no significant difference in the clinical effective rate between the two groups (P＞0.05).There was no significant difference in the incidence of adverse reactions between the two groups (P＞0.05).Conclusion Risperidone is effective in the treatment of schizophrenia.Compared with Olanzapine,Risperidone has fewer clinical adverse reactions,which is more conducive to the improvement of clinical symptoms,the improvement of serum indexes and the recovery of social function.

Key words： Risperidone Schizophrenia Clinical efficacy Serum index Social function

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WANG Tianming
	JIANG Xiaojian
	HUANG Deqiang

Cite this article:

WANG Tianming,JIANG Xiaojian,HUANG Deqiang. Application effect of Risperidone in patients with schizophrenia[J]. 中国当代医药, 2022, 29(7): 60-63.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2022/V29/I7/60

[1]	彭述珊，康艳宝，李登云.氟西汀联合利培酮治疗精神分裂症的疗效及其对患者血清miR-132 和miR-320 表达的影响[J].中国医师杂志，2020，22（4）：613-615.
[2]	李洁，李新纯，李杰，等.脑心同治针刺法联合利培酮对精神分裂症攻击行为及认知功能的临床疗效观察[J].湖南中医药大学学报，2020，40（10）：1244-1248.
[3]	王欣，张应全，陈军升，等.阴性和阳性症状精神分裂症患者内隐记忆特点及相关因素[J].中华行为医学与脑科学杂志，2021，30（3）：232-237.
[4]	于晓东，杨楹，刘增训，等.CYP2D6 基因多态性与利培酮治疗精神分裂症的相关性研究[J].精神医学杂志，2020，11（3）：613-614.
[5]	黄昱淳，裘建萍，李凤婷，等.利培酮联合抗抑郁药物治疗精神分裂症阴性症状研究进展[J].国际精神病学杂志，2020，47（5）：881-884.
[6]	中华医学会精神病学分会.中国精神障碍分类与诊断标准第三版（精神障碍分类）[J].中华精神科杂志，2001，34（3）：184-188.
[7]	李鲜鲜，张平，王芳，等.半封闭管理联合农场劳动对精神分裂症长期住院患者阴性症状的影响[J].神经疾病与精神卫生，2020，20（1）：26-31.
[8]	杨艳蓉，汪子琪，李铮，等.60 岁以上住院患者衰弱现状及其与认知功能的相关性分析[J].中国全科医学，2020，23（17）：2132-2136，2141.
[9]	白春明，郭剑，李满桂.精神分裂症患者脑脊液和血浆中溶血磷脂酸水平与阳性和阴性症状量表评分间的相关性分析[J].中华保健医学杂志，2020，11（1）：42-44.
[10]	吴艳，王珍宝，马贵君，等.精神分裂症患者居家自我管理现状及影响因素分析[J].中华现代护理杂志，2021，27（9）：1160-1165.
[11]	倪旭，汪南田.利培酮联合多奈哌齐治疗老年脑卒中后精神障碍和认知功能障碍的临床观察[J].老年医学与保健，2020，26（2）：295-298.
[12]	丁木兵，宋传福，蔡昌群，等.利培酮维持治疗精神分裂症的疗效和安全性研究[J].药物生物技术，2020，27（5）：433-437.
[13]	王焕明，刘鲁西，张国鲁.喹硫平和利培酮对老年脑血管病所致精神障碍患者的疗效[J].国际精神病学杂志，2020，47（4）：743-745.
[14]	Ramezani M，Ruskey JA，Martens K，et al.Association between BDNF Val66Met polymorphism and mild behavioral impairment in patients with Parkinson′s disease[J].Front Neurol，2021，11：587992.
[15]	K?ker SA，K?müroulu AU，Kgksoy AY，et al.Evaluation of GLUT1，IGF-2，VEGF，FGF1 and angiopoietin 2 in infantile hemangioma[J].Arch Pediatr，2021，28（4）：296-300.
[16]	Hu Y，Wen J，Zhang B，et al.Precision control of mTORC1 is crucial for the maintenance and IL-13 responsiveness of alveolar macrophages[J].Int Immunopharmacol，2021，95：107552.
[17]	熊倩，余建英，严凯，等.维思通与思瑞康治疗对住院男性精神分裂症患者增重内分泌和体内代谢的影响[J].河北医学，2020，26（3）：370-374.
[18]	邹展平，王美玲，涂剑江，等.利培酮对首发精神分裂症患者代谢指标的影响[J].浙江医学，2020，42（4）：1400-1402.